Lara D, van Dijk MG, García SG, Grossman D

Language: Spanish
References: 14
Page: 483-487
PDF size: 52.23 Kb.

ABSTRACT

Objectives: Understand the process of including Emergency Contraception (EC) in the Mexican Family Planning Norm (NOM) and identify factors that influenced this achievement.
Materials and methods: We conducted in-depth interviews with eight prominent decision-makers of state and federal government institutions.
Results: The determining factor for the inclusion of EC in the Norm was the external review of scientific evidence, done by experts from the National Centre for Equity of Gender and Reproductive Health, proving that EC pills are not abortifacients. Other important factors that contributed to the inclusion were the ample support of civil organizations, the population’s demand and the Minister of Health’s support of EC. The inclusion of EC in the essential drug list was perceived as a logical next step after its inclusion in the NOM.
Conclusions: The introduction of EC in Mexico highlights the importance of scientific evidence for decision-making. The process took about a decade, which reflects the complexity of converting research results into public policies. Measures should be taken to speed the processes that benefit women and society as a whole

REFERENCES

1. Consorcio Latinoamericano de Anticoncepción de Emergencia (CLAE). Cuadro resumen de la situación de la anticoncepción de emergencia en países latinoamericanos y del Caribe. Disponible en http://www.clae.info/Mecanismos_20 de_20Accion/cuadro_resu_nov05.doc (consultado el 6 de julio de 2006).

2. Trussell J, Rodríguez G, Ellertson C. New estimates of the effectiveness of the Yuzpe regimen of emergency contraception. Contraception 1998;57:363-369.

3. Secretaría de Salud. Resolución por la que se modifica la Norma Oficial Mexicana NOM-005-SSA2-1993, de los servicios de planificación familiar. México: Diario Oficial de la Federación, 21 de enero de 2004.

4. Secretaría de Salud. Actualización del Cuadro Básico de Medicamentos del Sector Salud. México: Diario Oficial de la Federación, 11 de julio de 2005.

5. Ellertson C, Heimburger A, Acevedo-García D, Schiavon R, Mejía G, Corona G, et al. Information Campaign and advocacy efforts to promote access to emergency contraception in Mexico. Contraception 2002;66:331-337.

6. The Population Council. Emergency contraception as an element in the care of rape victims. Mexico: Population Council; 1997.

7. García SG, Becker D, Martínez de Castro M, Paz F, Díaz-Olavarrieta C, Acevedo-García D. Knowledge and opinions of emergency contraceptive pills among female factory workers in Tijuana, Mexico: Insights from a worksite intervention. (Currently under review at Studies in Family Planning.)

8. Heimburger A, Acevedo-García D, Schiavon R, Langer A, Mejía G, Corona G, et al. Emergency contraception in México City: knowledge, attitudes, and practices among providers and clients after a 3-year introduction effort. Contraception 2002;66:321-329.

9. Population Council. Knowledge and opinions of emergency contraceptive pills in Mexico: Results of a nationally-representative survey. México: Population Council; 2001 (documento interno).

10. Secretaría de Salud. Encuesta Nacional de Salud Reproductiva. México: Secretaría de Salud; 2003.

11. Muhr T. User’s manual for Atlas.ti 5.0. Berlin, Alemania: Scientific Software Development; 2004.

12. Marions L, Hultenby K, Lindell I, Sun X, Stabi B, Danielsson KG. Emergency Contraception with mifepristone and levonorgestrel: mechanism of action. Obstet Gynecol 2002:100:65-71.

13. Hapagngam D, Glasier AF, Baird DT. The effects of peri-ovulatory administration of levonorgestrel on the menstrual cycle. Contraception 2001;63:123-129.

14. Population Council. Encuesta de opinión pública sobre el aborto 2006: Resultados preliminares. México: Population Council; 2007 (documento interno).